IPO Price Range: ₹54 - 54
Min Investment
₹1,08,000
IPO Status
Live
Quantity in 1 Lot
2000
Max Bid allowed
1
Listing Exchange
BSE
![]() | 13 Feb 2025 |
![]() | 17 Feb 2025 |
![]() | 18 Feb 2025 |
![]() | 2000 |
![]() | ₹1,08,000 |
Established and proven track record.
Leveraging the experience of our Promoters.
Experienced management team and a motivated and efficient work force.
Cordial relations with our customers.
Quality Assurance & Control.
Our Company, Directors, Promoters and Group Companies are parties to certain legal proceedings. Any adverse decision in such proceedings may have a material adverse effect on our business, results of operations and financialcondition
Our Company has limited operating history, and therefore investors may not be able to assess our prospects on the basis of historical results.
We are highly dependent on our healthcare professionals, including doctors, nurses that we engage on a consultancy basis, and our business and financial results could be impacted if we are not able to attract and retain such healthcare professionals.
Our Company is yet to place orders for medical equipment proposed to be installed at our hospital. Any delay in placing orders or procurement of such equipment may delay the schedule of implementation and possibly increase the cost of commencing operations.
We generate certain revenues from the arrangements with government sponsored health schemes, any adverse change in these regulations/government policies related to such schemes may adversely affect our business, results of operations, cash flows and prospects.
Delay in receipt of payment from our patients / customers may affect our cash flows, which may, in turn affect our financial condition and results of operations.
Our indebtedness and the conditions and restrictions imposed by our financing arrangements may limit our ability to grow our business and adversely impact our business.
Changes in healthcare laws, rules and regulations may materially adversely affect our business
Our Company had negative cash flow in recent fiscals, details of which are given below. Sustained negative cash flow could adversely impact our business, financial condition and results of operations.
There are certain instances of delays in the past with ROC/Statutory Authorities.
Investors | Holdings % |
Paneerselvam Palaniappan Shanm | 24.81% |
Prabhu Sankar Paneerselvam | 24.81% |
Priyadharshni Dhandapani | 24.81% |
Jayalakshmi Paneerselvam | 24.81% |